[ET Net News Agency, 27 August 2019] Austar Lifesciences Limited (06118) said its
profit attributable to owners of the company was RMB4.17 million for the six months ended
30 June 2019, compared to the loss of RMB3.73 million of the same period last year. The
earnings per share were RMB0.01. No dividend will be distributed.
The revenue was RMB477.79 million, a year-on-year increase of 45.46%. The gross profit
was RMB126.99 million, a year-on-year increase of 47.76%. (RC)